Wednesday, March 30, 2011

Too many old men get prostate cancer tests: study

Too many old men get prostate cancer tests: study: "NEW YORK (Reuters Health) - Many men in their 80s get regular blood tests for prostate cancer even though there's no evidence the tests will benefit them, according to a new study.

In older men, finding hidden prostate cancer might not be helpful, because the cancer might not shorten their lifespan. But once it's discovered, a very early-stage cancer usually leads to painful and expensive medical encounters.

So with elderly men, screening "makes no sense," Dr. Peter Albertsen, a prostate cancer researcher at University of Connecticut Health Center in Farmington who was not involved with the current study, told Reuters


Doctors may be used to ordering the prostate cancer blood tests in these men without really thinking about it.




"

Friday, March 25, 2011

Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study (HealthDay)

Short Course of Hormone Therapy Boosts Prostate Cancer Survival:
Study
(HealthDay)
: "HealthDay - THURSDAY, March 24 (HealthDay News) -- Just six months of hormone
therapy, along with radiation, cuts the risk of dying from locally
advanced prostate cancer in half when compared to radiation alone,
researchers report."

Tuesday, March 15, 2011

Men's fertility may be regained sugically after cancer

Surgery helps men regain fertility after cancer

(AP): "AP - New research shows a painstaking surgical technique can help some men deemed infertile because of childhood cancer treatment to become fathers after all."

Surgeons essentially perform tiny biopsies of testicular tissue to hunt any pockets of hidden sperm, which then are used in standard in vitro fertilization to attempt a partner's pregnancy.

In cancer survivors, they were able to extract small amounts of sperm from more than a third of the men — 27 of 73. Doctors then attempted injecting the sperm into a partner's eggs in hopes of pregnancy. The result: 20 children were born, including five pairs of twins, the researchers reported Monday in the Journal of Clinical Oncology.

Saturday, March 5, 2011

Key genital measurement linked to male fertility

Key genital measurement linked to male fertility: "WASHINGTON (Reuters) - When it comes to male fertility, it turns out that size does matter.

Men whose AGD is shorter than the median length -- around 2 inches (52 mm) -- have seven times the chance of being sub-fertile as those with a longer AGD, according to a study published on Friday in the journal Environmental Health Perspectives.

That distance, measured from the anus to the underside of the scrotum, is linked to male fertility, including semen volume and sperm count, the study found. The shorter the AGD, the more likely a man was to have a low sperm count.


"

Thursday, March 3, 2011

Painkiller Use Related to Erection Problems

Impotence more common in men who pop painkillers: "NEW YORK (Reuters Health) - Aging men tend to take more painkillers and experience more sexual problems, but does that mean one causes the other?

Researchers found that regular users of drugs like aspirin, acetaminophen, ibuprofen, and Celebrex were 38 percent more likely to have erectile dysfunction than men who didn't take the so-called nonsteroidal anti-inflammatory painkillers.

Such drugs are thought to block the hormones that govern men's erections.

After accounting for factors like age, weight, high blood pressure and heart disease, the researchers still found a 38-percent higher risk of erectile dysfunction among men on painkillers.

Still, because the study didn't test painkillers directly, Inman cautioned that men shouldn't stop using painkillers for fear that it would cut their chances of getting an erection.




"

Friday, February 25, 2011

PSA spikes are poor predictors of prostate cancer

PSA spikes are poor predictors of prostate cancer: "CHICAGO (Reuters) - A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S. researchers said on Thursday.

If a man's PSA has risen rapidly in recent years, there is no cause for concern if his total PSA level is still low and his clinical exam is normal.

He said the large study adds to others showing that changes in PSA should not be used alone as a basis for getting a biopsy. Besides cancer, other conditions, including an enlarged prostate and infections, can cause PSA levels to rise.

Once diagnosed, more than 90 percent of men with low-grade prostate cancer get treated, most often with surgery or radiation. Both can cause lasting side effects including impotence or incontinence.




"

Wednesday, February 16, 2011

Drug may slow growth of early prostate cancer (AP)

Drug may slow growth of early prostate cancer
(AP)
: "AP - A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away."

This is the first time that a drug for treating enlarged prostates also has been shown to help treat prostate cancer in a rigorous study. It may persuade more men to choose active surveillance, or "watchful waiting," instead of rushing to have treatments that can leave them with urinary or sexual problems, doctors say.

However, the results also show that most of these men do very well with no treatment at all.


Doctors know that drugs that shrink the prostate — GlaxoSmithKline PLC's Avodart and Merck & Co.'s Proscar — can help prevent prostate cancer. But federal health advisers recently recommended against taking them for this purpose because of potential risks.

The new study tested Avodart "not to prevent cancer, but to prevent the progression" of it in men who already have the disease, which may be a much better use of such drugs, said the study's leader, Dr. Neil Fleshner

Doctors don't think Avodart can cure cancers, but it seems to suppress it, said Dr. Howard Sandler, a prostate cancer specialist at Cedars-Sinai Medical Center in Los Angeles. He had no role in the study but is involved with the cancer conference.

Sandler said Avodart might relieve some men's anxiety about monitoring their disease and may make them more comfortable not having immediate treatment.